Deutsche Bank Ag\ Day One Biopharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 323,460 shares of DAWN stock, worth $4.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

323,460

Previous 201,867 60.23%

Holding current value

$4.14 Million

Previous $2.78 Million 61.99%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$12.72 - $16.03 $1.55 Million - $1.95 Million	121,593 Added 60.23%	323,460 $4.51 Million
Q2 2024 Aug 14, 2024	BUY	$12.03 - $17.69 $285,026 - $419,129	23,693 Added 13.3%	201,867 $2.78 Million
Q1 2024 May 15, 2024	BUY	$13.56 - $17.46 $13,804 - $17,774	1,018 Added 0.57%	178,174 $2.94 Million
Q4 2023 Feb 14, 2024	BUY	$9.68 - $15.37 $183 - $292	19 Added 0.01%	177,156 $2.59 Million
Q3 2023 Nov 09, 2023	BUY	$11.22 - $14.86 $103,437 - $136,994	9,219 Added 5.49%	177,137 $2.17 Million
Q2 2023 Aug 14, 2023	SELL	$11.74 - $14.47 $4,895 - $6,033	-417 Reduced 0.25%	167,918 $2 Million
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $1.93 Million - $3.55 Million	151,525 Added 901.4%	168,335 $2.25 Million
Q4 2022 Feb 13, 2023	BUY	$18.77 - $22.0 $97,829 - $114,664	5,212 Added 44.94%	16,810 $361,000
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $9,107 - $14,719	554 Added 5.02%	11,598 $232,000
Q2 2022 Aug 11, 2022	SELL	$5.72 - $17.9 $12,692 - $39,720	-2,219 Reduced 16.73%	11,044 $198,000
Q1 2022 May 13, 2022	BUY	$9.12 - $17.47 $59,836 - $114,620	6,561 Added 97.9%	13,263 $132,000
Q4 2021 Feb 11, 2022	BUY	$15.65 - $26.33 $5,680 - $9,557	363 Added 5.73%	6,702 $113,000
Q3 2021 Nov 04, 2021	BUY	$20.0 - $27.92 $126,780 - $176,984	6,339 New	6,339 $150,000

Others Institutions Holding DAWN

# of Institutions

178

Shares Held

84M

Call Options Held

144K

Put Options Held

218K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $940M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account